Postdoctoral Scientist
Quantitative Pharmacology & Pharmacometrics, Translational Medicine, Merck & Co., Inc., Rahway, NJ, USA
Abid Haque is a quantitative pharmacologist at Merck, specializing in physiologically based pharmacokinetic (PBPK) modeling to support dose predictions for clinical trials, specifically for Fc-engineered monoclonal antibody therapeutics. With a Ph.D. in quantitative biology and a background in mechanical engineering, he applies computational modeling and systems-level thinking to drug development, bridging preclinical and clinical pharmacology. His expertise spans nonlinear dynamics, emergent behavior, and ADME processes, driving inovation in translational pharmacokinetics.